Page last updated: 2024-11-01

nisoldipine and Angor Pectoris

nisoldipine has been researched along with Angor Pectoris in 50 studies

Nisoldipine: A dihydropyridine calcium channel antagonist that acts as a potent arterial vasodilator and antihypertensive agent. It is also effective in patients with cardiac failure and angina.
nisoldipine : A racemate consisting of equimolar amounts of (R)- and (S)-nisoldipine. A calcium channel blocker, it is used in the treatment of hypertension and angina pectoris.
methyl 2-methylpropyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a methoxycarbonyl group at position 3, an o-nitrophenyl group at position 4, and an isobutoxycarbonyl group at position 5. The racemate, a calcium channel blocker, is used in the treatment of hypertension and angina pectoris.

Research Excerpts

ExcerptRelevanceReference
"The efficacy and safety of nisoldipine-extended release (ER) and amlodipine were compared in a 6-week multicenter, randomized, double-blind, double-dummy, parallel group, titration-to-effect trial in patients with stage 1 to 2 systemic hypertension (90 to 109 mm Hg diastolic blood pressure [BP]) and chronic stable angina pectoris."9.10Comparison of effects of nisoldipine-extended release and amlodipine in patients with systemic hypertension and chronic stable angina pectoris. ( Bittar, N; Cooper-DeHoff, RM; Hutchinson, HG; Koren, M; Michelson, EL; Minkwitz, MC; Pepine, CJ; Thadani, U; Weiss, RJ, 2003)
"In 33 patients with stable angina pectoris, nisoldipine was tested (10 mg daily) in a randomized, double-blind, placebo-controlled study."9.08Antianginal and anti-ischemic efficacy of nisoldipine in stable angina pectoris: a randomized, double-blind, placebo-controlled trial. ( Chen, YH; Liu, RC; Wang, SP, 1996)
" Fifteen male patients with stable angina pectoris treated with atenolol were studied after undergoing routine cardiac catheterisation."9.07A comparison of the acute haemodynamic effects of nisoldipine and nifedipine during treatment with atenolol in patients with coronary artery disease. ( Dawkins, KD; Donaldson, KM; Waller, DG, 1993)
"5, 5, and 10 mg nisoldipine twice a day was not superior to placebo therapy in treating patients with angina pectoris, and the 10-mg-b."9.07Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris. ( Bittar, N; Chaitman, B; DiBianco, R; Glasser, S; Miller, AB; Montoro, R; Schulman, P; Stahl, A; Thadani, U; Zellner, SR, 1991)
"The duration and extent of antianginal effects of nisoldipine, a dihydropyridine calcium antagonist, were assessed in 178 patients with chronic stable angina pectoris."9.07Usefulness of oral nisoldipine for stable angina pectoris. The Nisoldipine Multicenter Angina Study Group. ( Frishman, WH; Heiman, M, 1991)
"In order to evaluate the benefits of a calcium-antagonist medium-term treatment, 20 patients with effort stable angina pectoris were treated with nisoldipine in comparison to diltiazem."9.07[Comparison of nisoldipine and diltiazem in the treatment of effort angina pectoris]. ( Cicatiello, AM; de Caprio, L; De Rosa, ML; di Palma, A; Lombardi, L; Pandolfi, E; Rengo, F; Santamaria, F; Sestito, M; Voza, A, 1994)
"The acute haemodynamic effects of intravenous nisoldipine and hydralazine were compared in nine patients with heart failure."9.06Comparative haemodynamic effects of intravenous nisoldipine and hydralazine in congestive heart failure. ( Angel, ME; Haitas, B; Meyer, TE; Reef, E, 1990)
"The effects of the long-acting dihydropyridine calcium antagonist nisoldipine coat core (CC) have been investigated in > 3,500 patients with angina pectoris, hypertension, and ischemic ventricular dysfunction."8.79Efficacy and safety of nisoldipine coat core in the management of angina pectoris, systemic hypertension, and ischemic ventricular dysfunction. ( Lewis, BS, 1995)
"The effects of the calcium antagonists nicardipine and nisoldipine on left ventricular (LV) metabolism were analyzed in 32 patients with angina pectoris."7.67Effects of nicardipine and nisoldipine on myocardial metabolism, coronary blood flow and oxygen supply in angina pectoris. ( Charlier, AA; Pouleur, H; Rousseau, MF; Van den Berghe, G; Van Hoof, F; Vincent, MF, 1984)
"In atenolol-treated patients with severe effort angina pectoris, nifedipine 20 mg tid improved exercise capacity, while nisoldipine 20 mg once daily did not have a similar effect."6.67Nisoldipine tablets once daily versus nifedipine capsules three times daily in patients with stable effort angina pectoris pretreated with atenolol. ( Kantor, M; Pedersen, TR, 1990)
" This trial confirms that immediate-release nisoldipine when added to existent beta-blocker therapy is an active antianginal and anti-ischemic agent, but that the immediate-release formulation loses its antianginal effect at the end of its dosing interval (9 to 14 hours)."6.67Antianginal and anti-ischemic efficacy of immediate-release nisoldipine in chronic stable angina pectoris. ( Bittar, N; Glasser, SP; Katz, R; Labreche, DG; Schulman, P; Singh, B, 1994)
"Nisoldipine is a second-generation dihydropyridine calcium channel blocker (CCB)."6.40Nisoldipine CC: efficacy and tolerability in hypertension and ischemic heart disease. ( Fodor, JG, 1997)
"Nisoldipine is a second-generation dihydropyridine calcium antagonist that has been extensively studied as an antianginal and antihypertensive agent."6.39Nisoldipine coat core as concomitant therapy in chronic stable angina pectoris. ( Glasser, SP, 1995)
"Nisoldipine is an orally administered calcium entry blocking drug structurally related to nifedipine."6.37Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders. ( Friedel, HA; Sorkin, EM, 1988)
"The efficacy and safety of nisoldipine-extended release (ER) and amlodipine were compared in a 6-week multicenter, randomized, double-blind, double-dummy, parallel group, titration-to-effect trial in patients with stage 1 to 2 systemic hypertension (90 to 109 mm Hg diastolic blood pressure [BP]) and chronic stable angina pectoris."5.10Comparison of effects of nisoldipine-extended release and amlodipine in patients with systemic hypertension and chronic stable angina pectoris. ( Bittar, N; Cooper-DeHoff, RM; Hutchinson, HG; Koren, M; Michelson, EL; Minkwitz, MC; Pepine, CJ; Thadani, U; Weiss, RJ, 2003)
"In 33 patients with stable angina pectoris, nisoldipine was tested (10 mg daily) in a randomized, double-blind, placebo-controlled study."5.08Antianginal and anti-ischemic efficacy of nisoldipine in stable angina pectoris: a randomized, double-blind, placebo-controlled trial. ( Chen, YH; Liu, RC; Wang, SP, 1996)
" Fifteen male patients with stable angina pectoris treated with atenolol were studied after undergoing routine cardiac catheterisation."5.07A comparison of the acute haemodynamic effects of nisoldipine and nifedipine during treatment with atenolol in patients with coronary artery disease. ( Dawkins, KD; Donaldson, KM; Waller, DG, 1993)
"The aim of this study was to investigate the anti-ischemic and antianginal activity and the duration of the new dihydropyridine calcium blocker nisoldipine (NIS) in patients with stable angina pectoris."5.07Effect of calcium antagonists on exercise tests. ( Cherchi, A; Cherchi, PA; Lai, C; Lai, G; Onnis, E; Solinas, R, 1992)
"The duration and extent of antianginal effects of nisoldipine, a dihydropyridine calcium antagonist, were assessed in 178 patients with chronic stable angina pectoris."5.07Usefulness of oral nisoldipine for stable angina pectoris. The Nisoldipine Multicenter Angina Study Group. ( Frishman, WH; Heiman, M, 1991)
"5, 5, and 10 mg nisoldipine twice a day was not superior to placebo therapy in treating patients with angina pectoris, and the 10-mg-b."5.07Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris. ( Bittar, N; Chaitman, B; DiBianco, R; Glasser, S; Miller, AB; Montoro, R; Schulman, P; Stahl, A; Thadani, U; Zellner, SR, 1991)
"The effects of the addition of slow-release nifedipine 20 mg twice daily and nisoldipine 10 mg twice daily to atenolol monotherapy were compared in a double-blind placebo-controlled study of 24 patients with chronic stable angina pectoris."5.07A comparison of nisoldipine and nifedipine, in combination with atenolol, in the management of myocardial ischaemia. ( Dawkins, KD; Donaldson, KM; Waller, DG, 1993)
"In order to evaluate the benefits of a calcium-antagonist medium-term treatment, 20 patients with effort stable angina pectoris were treated with nisoldipine in comparison to diltiazem."5.07[Comparison of nisoldipine and diltiazem in the treatment of effort angina pectoris]. ( Cicatiello, AM; de Caprio, L; De Rosa, ML; di Palma, A; Lombardi, L; Pandolfi, E; Rengo, F; Santamaria, F; Sestito, M; Voza, A, 1994)
"We studied the short-term effects of oral administration of nisoldipine (10 mg) and propranolol (80 mg) alone and in combination in 14 patients with chronic exertional angina pectoris in a double-blind, randomized, cross-over study."5.06Acute effects of nisoldipine, propranolol, and their combination in patients with chronic stable angina: a double-blind, randomized, cross-over, placebo-controlled study. ( Abete, P; Acanfora, D; Cicatiello, AM; Covelluzzi, F; De Caprio, L; Gallucci, F; Papa, M; Rengo, F, 1990)
"The acute haemodynamic effects of intravenous nisoldipine and hydralazine were compared in nine patients with heart failure."5.06Comparative haemodynamic effects of intravenous nisoldipine and hydralazine in congestive heart failure. ( Angel, ME; Haitas, B; Meyer, TE; Reef, E, 1990)
"To investigate the mechanism of antianginal action of the calcium channel blocker nisoldipine and to determine the reproducibility of the clinical and hemodynamic events induced by supine leg exercise, 30 patients with stable effort angina pectoris were studied."5.06Hemodynamic mechanisms of antianginal action of calcium channel blocker nisoldipine in dynamic exercise-induced angina. ( Iwase, M; Kamihara, S; Koide, M; Matsunami, T; Miyahara, T; Saito, H; Takeuchi, J; Watanabe, M; Yokota, M, 1990)
"The effects of the long-acting dihydropyridine calcium antagonist nisoldipine coat core (CC) have been investigated in > 3,500 patients with angina pectoris, hypertension, and ischemic ventricular dysfunction."4.79Efficacy and safety of nisoldipine coat core in the management of angina pectoris, systemic hypertension, and ischemic ventricular dysfunction. ( Lewis, BS, 1995)
"The purpose of this study was to determine the response of plasma levels of endothelin-1 (ET-1) to dynamic exercise in patients with coronary artery disease and chronic stable angina pectoris and positive exercise tolerance test, before and after treatment with the calcium antagonist nisoldipine (20 mg/day buccally for 7 days)."3.69Plasma endothelin-1 concentrations in patients with coronary artery disease during stress test before and after nisoldipine administration. ( Barillà, F; Campa, PP; Cerci, S; Coassin, S; D'Ambrosio, C; De Ciocchis, A; Letizia, C; Mastroianni, MA; Scavo, D, 1996)
"To evaluate the effects of antianginal agents on the correlation between rate-pressure product and myocardial oxygen uptake, multistage supine leg exercise tests were performed by 21 patients with stable effort-induced angina pectoris before and after administration of antianginal drugs (a calcium channel blocker of the dihydropyridine class [10 mg of nisoldipine orally] in 11 patients and a beta-blocker [0."3.68Effect of antianginal agents on the relationship between rate-pressure product and myocardial oxygen uptake. ( Kodama, Y; Matsunami, T; Miyahara, T; Saito, H; Sobue, T; Yokota, M, 1993)
"The effects of the calcium antagonists nicardipine and nisoldipine on left ventricular (LV) metabolism were analyzed in 32 patients with angina pectoris."3.67Effects of nicardipine and nisoldipine on myocardial metabolism, coronary blood flow and oxygen supply in angina pectoris. ( Charlier, AA; Pouleur, H; Rousseau, MF; Van den Berghe, G; Van Hoof, F; Vincent, MF, 1984)
" Among 15 patients with coronary artery disease who had been treated with nisoldipine, onset of severe unstable angina was observed in 2 and evolution of acute myocardial infarction in 1 patient after abrupt withdrawal of nisoldipine therapy."3.67Calcium-blocker withdrawal phenomenon: increase in affinity of alpha 2 adrenoceptors for agonist as a potential mechanism. ( Lopez, LM; Mehta, J, 1986)
" This trial confirms that immediate-release nisoldipine when added to existent beta-blocker therapy is an active antianginal and anti-ischemic agent, but that the immediate-release formulation loses its antianginal effect at the end of its dosing interval (9 to 14 hours)."2.67Antianginal and anti-ischemic efficacy of immediate-release nisoldipine in chronic stable angina pectoris. ( Bittar, N; Glasser, SP; Katz, R; Labreche, DG; Schulman, P; Singh, B, 1994)
"In atenolol-treated patients with severe effort angina pectoris, nifedipine 20 mg tid improved exercise capacity, while nisoldipine 20 mg once daily did not have a similar effect."2.67Nisoldipine tablets once daily versus nifedipine capsules three times daily in patients with stable effort angina pectoris pretreated with atenolol. ( Kantor, M; Pedersen, TR, 1990)
"A double-blind, placebo-controlled study was performed to assess whether a new calcium antagonist, nisoldipine, in doses of either 5 mg or 10 mg daily, in combination with beta-adrenergic-blocking drugs (combination therapy) was more effective than beta-adrenergic-blocking drugs alone (single therapy) in the treatment of chronic stable angina."2.66Efficacy of nisoldipine combined with beta-adrenergic-blocking drugs in the treatment of chronic stable angina. ( Banim, SO; Creamer, JE; O'Keefe, JC, 1987)
"Nisoldipine is an effective antianginal agent which performs well in comparison to nifedipine."2.66Comparative antianginal effects of nisoldipine and nifedipine in patients with chronic stable angina. ( Chaitman, BR; Crean, PA; Lam, J; Waters, DD, 1987)
"Nisoldipine is a second-generation dihydropyridine calcium channel blocker (CCB)."2.40Nisoldipine CC: efficacy and tolerability in hypertension and ischemic heart disease. ( Fodor, JG, 1997)
"Nisoldipine is a second-generation dihydropyridine calcium antagonist that has been extensively studied as an antianginal and antihypertensive agent."2.39Nisoldipine coat core as concomitant therapy in chronic stable angina pectoris. ( Glasser, SP, 1995)
" The most optimal dosage regimen has not been established in clinical trials."2.38Nisoldipine: a new dihydropyridine calcium-channel blocker. ( Frishman, W; Heiman, M; Mitchell, J, 1993)
"Nisoldipine is an orally administered calcium entry blocking drug structurally related to nifedipine."2.37Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders. ( Friedel, HA; Sorkin, EM, 1988)
"Thus nisoldipine acts as a peripheral dilating agent, decreasing arteriolar tone and, possible, venous tone, and increasing left ventricular muscle distensibility."1.28Haemodynamic effects of nisoldipine by oral route. ( Boffa, GM; Calvanese, A; Chioin, R; Isabella, G; Ramondo, A; Razzolini, R, 1991)

Research

Studies (50)

TimeframeStudies, this research(%)All Research%
pre-199015 (30.00)18.7374
1990's34 (68.00)18.2507
2000's1 (2.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pepine, CJ1
Cooper-DeHoff, RM1
Weiss, RJ1
Koren, M1
Bittar, N4
Thadani, U2
Minkwitz, MC1
Michelson, EL1
Hutchinson, HG1
Donaldson, KM2
Dawkins, KD2
Waller, DG2
Brügmann, U1
Blasini, R1
Rudolph, W1
Hess, OM1
Krayenbühl, HP1
Rousseau, MF1
Vincent, MF1
Van Hoof, F1
Van den Berghe, G1
Charlier, AA1
Pouleur, H1
Smith, FB1
Helms, RW1
Lewis, BS1
Glasser, SP3
Ogawa, H1
Yasue, H1
Nakamura, N1
Fujii, H1
Miyagi, H1
Kikuta, K1
Labreche, DG1
Singh, B1
Katz, R1
Schulman, P2
de Caprio, L3
Sestito, M1
Pandolfi, E1
Santamaria, F1
di Palma, A1
Lombardi, L1
Voza, A1
De Rosa, ML1
Cicatiello, AM2
Rengo, F3
Grönefeld, G1
Bernhardt, J1
Schneider, W1
Kodama, Y1
Yokota, M2
Miyahara, T2
Matsunami, T2
Sobue, T1
Saito, H2
Sheiban, I1
Tonni, S1
Benussi, P1
Marini, A1
Trevi, GP1
Mitchell, J1
Frishman, W1
Heiman, M2
Ripa, S1
Garland, WT1
Weiss, R1
Nademanee, K1
Singh, S1
Mori, T1
Ishigai, Y1
Fukuzawa, A1
Chiba, K1
Shibano, T1
Letizia, C1
Barillà, F1
Cerci, S1
De Ciocchis, A1
Coassin, S1
Mastroianni, MA1
D'Ambrosio, C1
Campa, PP1
Scavo, D1
Chen, YH1
Liu, RC1
Wang, SP1
Fodor, JG1
Gheorghiade, M1
Lai, C1
Cherchi, A1
Onnis, E1
Solinas, R1
Lai, G1
Cherchi, PA1
Eber, B1
Schumacher, M1
Zweiker, R1
Pokan, R1
Klein, W1
Fresco, C1
Papa, M2
Acanfora, D2
Abete, P1
Gallucci, F2
Covelluzzi, F2
Krivonkin, KIu1
Belousov, IuB1
Frishman, WH1
Razzolini, R1
Boffa, GM1
Calvanese, A1
Isabella, G1
Ramondo, A1
Chioin, R1
Zellner, SR1
Glasser, S1
Montoro, R1
Miller, AB1
Chaitman, B1
Stahl, A1
DiBianco, R1
Waters, D1
Godfraind, T1
Kilz, U1
Knaup, G1
Petretta, M1
Morgano, G1
Arrichiello, P1
Breglio, R1
Lanzillo, T1
Mazza, F1
Bonaduce, D1
Pedersen, TR1
Kantor, M1
Haitas, B1
Meyer, TE1
Angel, ME1
Reef, E1
Iwase, M1
Watanabe, M1
Kamihara, S1
Koide, M1
Takeuchi, J1
Kimball, BP1
Watson, KR1
Bui, S1
Frankel, D1
Gansser, RE1
Bachmann, KF1
O'Keefe, JC1
Creamer, JE1
Banim, SO1
Ram, J1
Freedman, SB1
Ogasawara, S1
Thomson, A1
Kelly, DT1
Mehta, J1
Lopez, LM2
Friedel, HA1
Sorkin, EM1
Leosco, D1
Borgnino, C1
Cicatiello, M1
Cosentino, F1
Singer, M1
Trotman, IF1
Crean, PA1
Waters, DD2
Lam, J2
Chaitman, BR2
Lagioia, R1
Scrutinio, D1
Mangini, SG1
Accettura, D1
Mastropasqua, F1
Caporale, R1
Caiati, C1
Zanna, D1
Chiddo, A1
Rizzon, P1
Silke, B1
Verma, SP1
Midtbo, KA1
Müller, P1
Frais, MA1
Reynolds, G1
Taylor, SH1
Crean, P1
Blum, R1
Rubin, MR1
Holland, JP1
Mehta, JL1

Reviews

7 reviews available for nisoldipine and Angor Pectoris

ArticleYear
Efficacy and safety of nisoldipine coat core in the management of angina pectoris, systemic hypertension, and ischemic ventricular dysfunction.
    The American journal of cardiology, 1995, Apr-27, Volume: 75, Issue:13

    Topics: Angina Pectoris; Delayed-Action Preparations; Humans; Hypertension; Myocardial Infarction; Nisoldipi

1995
Nisoldipine coat core as concomitant therapy in chronic stable angina pectoris.
    The American journal of cardiology, 1995, Apr-27, Volume: 75, Issue:13

    Topics: Adrenergic beta-Antagonists; Angina Pectoris; Chronic Disease; Delayed-Action Preparations; Drug The

1995
Nisoldipine: a new dihydropyridine calcium-channel blocker.
    Journal of clinical pharmacology, 1993, Volume: 33, Issue:1

    Topics: Angina Pectoris; Cardiovascular Diseases; Heart Rate; Hemodynamics; Humans; Hypertension; Nisoldipin

1993
Nisoldipine CC: efficacy and tolerability in hypertension and ischemic heart disease.
    Cardiovascular drugs and therapy, 1997, Volume: 10 Suppl 3

    Topics: Aging; Angina Pectoris; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Delayed-A

1997
[Nisoldipine in comparison with long-term nitrates].
    Acta medica Austriaca, 1992, Volume: 19, Issue:5

    Topics: Angina Pectoris; Animals; Coronary Circulation; Coronary Disease; Coronary Vasospasm; Humans; Myocar

1992
[Clinical pharmacology of nisoldipine, a new calcium antagonist].
    Kardiologiia, 1991, Volume: 31, Issue:9

    Topics: Angina Pectoris; Animals; Cardiovascular Diseases; Drug Interactions; Humans; Hypertension; Nisoldip

1991
Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders.
    Drugs, 1988, Volume: 36, Issue:6

    Topics: Angina Pectoris; Calcium Channel Blockers; Cardiovascular Diseases; Humans; Hypertension; Nifedipine

1988

Trials

26 trials available for nisoldipine and Angor Pectoris

ArticleYear
Comparison of effects of nisoldipine-extended release and amlodipine in patients with systemic hypertension and chronic stable angina pectoris.
    The American journal of cardiology, 2003, Feb-01, Volume: 91, Issue:3

    Topics: Amlodipine; Angina Pectoris; Calcium Channel Blockers; Delayed-Action Preparations; Double-Blind Met

2003
A comparison of the acute haemodynamic effects of nisoldipine and nifedipine during treatment with atenolol in patients with coronary artery disease.
    British journal of clinical pharmacology, 1993, Volume: 36, Issue:4

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Blood Pressure; Calcium Channel

1993
[Comparison of the anti-ischemia effect of nisoldipine and verapamil. Double-blind randomized cross-over and placebo-controlled acute and long-term study].
    Herz, 1984, Volume: 9, Issue:4

    Topics: Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Diseas

1984
Comparison of efficacy of nisoldipine, metoprolol, and isosorbide dinitrate in patients with stable exertional angina: a randomized, cross-over, placebo-controlled study.
    International journal of cardiology, 1995, Volume: 48, Issue:2

    Topics: Administration, Oral; Aged; Angina Pectoris; Blood Pressure; Cross-Over Studies; Exercise Test; Exer

1995
Antianginal and anti-ischemic efficacy of immediate-release nisoldipine in chronic stable angina pectoris.
    The American journal of cardiology, 1994, Jun-15, Volume: 73, Issue:16

    Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Blood Pressure; Chronic Disease; Double-Blind M

1994
[Comparison of nisoldipine and diltiazem in the treatment of effort angina pectoris].
    Giornale italiano di cardiologia, 1994, Volume: 24, Issue:2

    Topics: Administration, Oral; Adult; Angina Pectoris; Diltiazem; Double-Blind Method; Electrocardiography; E

1994
[Dose-response relationship of nisoldipine in patients with stable angina pectoris and stress-induced myocardial ischemia].
    Zeitschrift fur Kardiologie, 1993, Volume: 82, Issue:9

    Topics: Adult; Aged; Angina Pectoris; Cardiac Catheterization; Coronary Disease; Delayed-Action Preparations

1993
Left ventricular dysfunction following transient ischaemia induced by transluminal coronary angioplasty. Beneficial effects of calcium antagonists against post-ischaemic myocardial stunning.
    European heart journal, 1993, Volume: 14 Suppl A

    Topics: Adult; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Coronary Circulation; Coronary Disease

1993
A comparison of nisoldipine and nifedipine, in combination with atenolol, in the management of myocardial ischaemia.
    European heart journal, 1993, Volume: 14, Issue:4

    Topics: Adult; Aged; Angina Pectoris; Atenolol; Delayed-Action Preparations; Dose-Response Relationship, Dru

1993
Antianginal and antiischemic efficacy of monotherapy extended-release nisoldipine (Coat Core) in chronic stable angina.
    Journal of clinical pharmacology, 1995, Volume: 35, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Calcium Channel Blockers; Chronic Disease; Delayed-

1995
Antianginal and anti-ischemic efficacy of nisoldipine in stable angina pectoris: a randomized, double-blind, placebo-controlled trial.
    Zhonghua yi xue za zhi = Chinese medical journal; Free China ed, 1996, Volume: 58, Issue:5

    Topics: Aged; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Drug Administr

1996
Effect of calcium antagonists on exercise tests.
    Journal of cardiovascular pharmacology, 1992, Volume: 20 Suppl 5

    Topics: Adult; Aged; Analysis of Variance; Angina Pectoris; Blood Pressure; Double-Blind Method; Electrocard

1992
Acute effects of nisoldipine, propranolol, and their combination in patients with chronic stable angina: a double-blind, randomized, cross-over, placebo-controlled study.
    Journal of cardiovascular pharmacology, 1990, Volume: 16, Issue:2

    Topics: Aged; Angina Pectoris; Double-Blind Method; Drug Therapy, Combination; Exercise Test; Female; Hemody

1990
Usefulness of oral nisoldipine for stable angina pectoris. The Nisoldipine Multicenter Angina Study Group.
    The American journal of cardiology, 1991, Oct-15, Volume: 68, Issue:10

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Angina Pectoris; Double-Blind Method; Electroc

1991
Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.
    Circulation, 1991, Volume: 84, Issue:6

    Topics: Adult; Angina Pectoris; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Exerc

1991
[Nisoldipine in stable angina pectoris. Efficacy and tolerance in comparison with diltiazem].
    Fortschritte der Medizin, 1991, May-10, Volume: 109, Issue:14

    Topics: Adult; Aged; Angina Pectoris; Diltiazem; Exercise Test; Female; Hemodynamics; Humans; Male; Middle A

1991
[Nisoldipine in the therapy of stable exercise angina: evaluation of its efficacy in ergometric tests compared with propranolol].
    Giornale italiano di cardiologia, 1990, Volume: 20, Issue:6

    Topics: Adult; Angina Pectoris; Coronary Circulation; Exercise; Exercise Test; Female; Humans; Male; Middle

1990
Nisoldipine tablets once daily versus nifedipine capsules three times daily in patients with stable effort angina pectoris pretreated with atenolol.
    Cardiovascular drugs and therapy, 1990, Volume: 4, Issue:2

    Topics: Adult; Angina Pectoris; Atenolol; Blood Pressure; Capsules; Double-Blind Method; Drug Administration

1990
Comparative haemodynamic effects of intravenous nisoldipine and hydralazine in congestive heart failure.
    British journal of clinical pharmacology, 1990, Volume: 29, Issue:3

    Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Cardiac Output; Heart Failur

1990
Hemodynamic mechanisms of antianginal action of calcium channel blocker nisoldipine in dynamic exercise-induced angina.
    Circulation, 1990, Volume: 81, Issue:6

    Topics: Adult; Aged; Angina Pectoris; Coronary Angiography; Coronary Circulation; Electrocardiography; Exerc

1990
Efficacy of nisoldipine combined with beta-adrenergic-blocking drugs in the treatment of chronic stable angina.
    Clinical cardiology, 1987, Volume: 10, Issue:6

    Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Chronic Disease; Coronary Angiography; Double-Bl

1987
[Acute effects of nisoldipine in patients with stable effort angina].
    Cardiologia (Rome, Italy), 1988, Volume: 33, Issue:10

    Topics: Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Double-Blind Method; Exercise T

1988
Use of exercise Doppler for non-invasive haemodynamic optimization of dose and identification of poor responders to an oral anti-anginal agent. A double-blind dose-finding study of nisoldipine.
    Postgraduate medical journal, 1988, Volume: 64, Issue:756

    Topics: Administration, Oral; Angina Pectoris; Aorta; Blood Flow Velocity; Calcium Channel Blockers; Clinica

1988
Comparative antianginal effects of nisoldipine and nifedipine in patients with chronic stable angina.
    American heart journal, 1987, Volume: 113, Issue:2 Pt 1

    Topics: Aged; Angina Pectoris; Calcium Channel Blockers; Chronic Disease; Clinical Trials as Topic; Double-B

1987
A haemodynamic study of the effects of combined slow-calcium channel blockade (nisoldipine) and beta-blockade (metoprolol) in coronary heart disease.
    International journal of cardiology, 1986, Volume: 13, Issue:2

    Topics: Adult; Angina Pectoris; Calcium Channel Blockers; Coronary Disease; Drug Therapy, Combination; Hemod

1986
A dose-ranging, placebo-controlled, double-blind trial of nisoldipine in effort angina: duration and extent of antianginal effects.
    Journal of the American College of Cardiology, 1985, Volume: 6, Issue:2

    Topics: Aged; Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Disease; Dose-Re

1985

Other Studies

17 other studies available for nisoldipine and Angor Pectoris

ArticleYear
[Antianginal effect of calcium antagonists, using nisoldipine as an example].
    Schweizerische medizinische Wochenschrift, 1984, Aug-18, Volume: 114, Issue:33

    Topics: Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Electrocardiography; Exercise Test; Heart

1984
Effects of nicardipine and nisoldipine on myocardial metabolism, coronary blood flow and oxygen supply in angina pectoris.
    The American journal of cardiology, 1984, Dec-01, Volume: 54, Issue:10

    Topics: Aged; Angina Pectoris; Calcium Channel Blockers; Coronary Circulation; Hemodynamics; Humans; Lactate

1984
EM mixed model analysis of data from informatively censored normal distributions.
    Biometrics, 1995, Volume: 51, Issue:2

    Topics: Algorithms; Angina Pectoris; Controlled Clinical Trials as Topic; Cross-Over Studies; Dose-Response

1995
Effect of antianginal agents on the relationship between rate-pressure product and myocardial oxygen uptake.
    American heart journal, 1993, Volume: 126, Issue:3 Pt 1

    Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Coronary Angiography; Drug Evaluation; Electrocardiogr

1993
Pharmacological profile of semotiadil fumarate, a novel calcium antagonist, in rat experimental angina model.
    British journal of pharmacology, 1995, Volume: 116, Issue:1

    Topics: Acetylcholine; Angina Pectoris; Animals; Arginine Vasopressin; Calcium Channel Blockers; Coronary Ve

1995
Plasma endothelin-1 concentrations in patients with coronary artery disease during stress test before and after nisoldipine administration.
    Acta cardiologica, 1996, Volume: 51, Issue:2

    Topics: Adult; Aged; Angina Pectoris; Calcium Channel Blockers; Coronary Disease; Endothelins; Exercise Test

1996
Nisoldipine and myocardial infarction.
    The New England journal of medicine, 1998, Jul-09, Volume: 339, Issue:2

    Topics: Angina Pectoris; Calcium Channel Blockers; Humans; Myocardial Ischemia; Nisoldipine

1998
Efficacy of nisoldipine.
    Circulation, 1992, Volume: 86, Issue:4

    Topics: Angina Pectoris; Humans; Nisoldipine

1992
Haemodynamic effects of nisoldipine by oral route.
    Pharmacological research, 1991, Volume: 24, Issue:3

    Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Blood Pressure; Cardiac Output; Hemodynamics; Hu

1991
Proischemic complications of dihydropyridine calcium channel blockers.
    Circulation, 1991, Volume: 84, Issue:6

    Topics: Angina Pectoris; Coronary Disease; Coronary Vessels; Humans; Nisoldipine

1991
Is the combination between beta-blockers and calcium antagonists appropriate in the management of angina pectoris?
    Acta clinica Belgica, 1990, Volume: 45, Issue:3

    Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Drug Synergism; Drug Therapy

1990
Preservation of left ventricular performance with reduced ischemic dysfunction by intravenous nisoldipine.
    The American journal of cardiology, 1990, Aug-15, Volume: 66, Issue:4

    Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Female; Heart; Humans; Infusions, Intravenous; Injec

1990
Dilatation of epicardial coronary arteries and attenuation of provoked coronary vasoconstriction by nisoldipine.
    European heart journal, 1989, Volume: 10 Suppl F

    Topics: Adult; Aged; Angina Pectoris; Coronary Angiography; Coronary Vessels; Ergonovine; Female; Hemodynami

1989
Effects of nisoldipine on systemic and leg blood flow, oxygen transport and metabolism, and hemodynamics during exercise in effort angina pectoris.
    The American journal of cardiology, 1989, Apr-01, Volume: 63, Issue:12

    Topics: Adult; Angina Pectoris; Cardiac Output; Heart Rate; Hemodynamics; Humans; Lactates; Lactic Acid; Leg

1989
Calcium-blocker withdrawal phenomenon: increase in affinity of alpha 2 adrenoceptors for agonist as a potential mechanism.
    The American journal of cardiology, 1986, Aug-01, Volume: 58, Issue:3

    Topics: Adult; Angina Pectoris; Blood Platelets; Calcium Channel Blockers; Coronary Disease; Epinephrine; Hu

1986
[Acute effects of various doses of nisoldipine in stable exertional angina].
    Cardiologia (Rome, Italy), 1987, Volume: 32, Issue:7

    Topics: Adult; Aged; Angina Pectoris; Dose-Response Relationship, Drug; Exercise Test; Female; Humans; Male;

1987
Improvement in exercise performance with nisoldipine, a new second-generation calcium blocker, in stable angina patients.
    American heart journal, 1985, Volume: 110, Issue:5

    Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship,

1985